Hhlr Advisors, Ltd. Bridge Bio Pharma, Inc. Transaction History

Hhlr Advisors, Ltd.

$4.36 Billion
Q3 2024

A detailed history of Hhlr Advisors, Ltd. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Hhlr Advisors, Ltd. holds 1,023,950 shares of BBIO stock, worth $23.6 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

1,023,950

Previous 1,390,653 26.37%

Holding current value

$23.6 Million

Previous $35.2 Million 25.99%

% of portfolio

0.6%

Previous 0.91%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.91 - $31.3 $8.77 Million - $11.5 Million	-366,703 Reduced 26.37%	1,023,950 $26.1 Million
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $532,772 - $719,010	23,164 Added 1.69%	1,390,653 $35.2 Million
Q1 2024 May 14, 2024	SELL	$27.35 - $40.45 $649,589 - $960,727	-23,751 Reduced 1.71%	1,367,489 $42.3 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $33.4 Million - $61.1 Million	-1,391,510 Reduced 50.0%	1,391,240 $56.2 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $3.56 Million - $7.38 Million	-210,697 Reduced 7.04%	2,782,750 $73.4 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $13.1 Million - $17.7 Million	-984,963 Reduced 24.76%	2,993,447 $51.5 Million
Q1 2023 May 15, 2023	SELL	$7.17 - $18.55 $8.67 Million - $22.4 Million	-1,208,815 Reduced 23.3%	3,978,410 $66 Million
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $1.18 Million - $2.01 Million	-174,789 Reduced 3.26%	5,187,225 $39.5 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $36.1 Million - $47.1 Million	650,410 Added 13.8%	5,362,014 $330 Million
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $5.2 Million - $11.7 Million	322,914 Added 7.36%	4,711,604 $137 Million
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $41 Million - $65.9 Million	2,035,790 Added 86.52%	4,388,690 $94.2 Million
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $63.5 Million - $64.8 Million	2,352,900 New	2,352,900 $63.5 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.42B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Hhlr Advisors, Ltd. with notifications on news.

Account

Hhlr Advisors, Ltd. Bridge Bio Pharma, Inc. Transaction History